Recruitment for this study is now closed. Thank you to everyone who participated.
This study aims to explore the effect of a new medicine after a single intravenous infusion (delivered directly into the vein) in volunteers. The researchers will compare the effect of the new medicine in healthy Caucasian subjects with that of healthy Japanese subjects.
For this study we need the help of male participants or female participants, of Caucasian descent, aged from 20 to 54 (inclusive) who are in good health and do not smoke or have a history of alcohol abuse or drug addiction. This study, which is only being conducted at Scientia Clinical Research in Randwick, will enrol up to 18 Caucasian volunteers with additional volunteers added if required.
All meals are provided during your stay, along with free Wi-Fi and use of gaming consoles.
Eligible participants will be reimbursed for their time.
The new medicine could possibly reduce the rate of cardiovascular death, myocardial infarction and stroke in acute coronary syndrome patients, if successful.
If you meet the criteria for this study and would like more information, register below or call 1800 727 874.